215 related articles for article (PubMed ID: 23948137)
1. Bulk, surface properties and water uptake mechanisms of salt/acid amorphous composite systems.
Bianco S; Tewes F; Tajber L; Caron V; Corrigan OI; Healy AM
Int J Pharm; 2013 Nov; 456(1):143-52. PubMed ID: 23948137
[TBL] [Abstract][Full Text] [Related]
2. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
3. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
4. Modification of the solid-state nature of sulfathiazole and sulfathiazole sodium by spray drying.
Bianco S; Caron V; Tajber L; Corrigan OI; Nolan L; Hu Y; Healy AM
AAPS PharmSciTech; 2012 Jun; 13(2):647-60. PubMed ID: 22549223
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
[TBL] [Abstract][Full Text] [Related]
6. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
7. Effect of counterions on the properties of amorphous atorvastatin salts.
Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK
Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794
[TBL] [Abstract][Full Text] [Related]
8. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical micro-particles give amorphous sucrose higher physical stability.
Hellrup J; Mahlin D
Int J Pharm; 2011 May; 409(1-2):96-103. PubMed ID: 21356288
[TBL] [Abstract][Full Text] [Related]
10. A study of the differences between two amorphous spray-dried samples of cefditoren pivoxil which exhibited different physical stabilities.
Ohta M; Buckton G
Int J Pharm; 2005 Jan; 289(1-2):31-8. PubMed ID: 15652196
[TBL] [Abstract][Full Text] [Related]
11. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of blends of paracetamol and citric acid.
Hoppu P; Jouppila K; Rantanen J; Schantz S; Juppo AM
J Pharm Pharmacol; 2007 Mar; 59(3):373-81. PubMed ID: 17331340
[TBL] [Abstract][Full Text] [Related]
13. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
Ambrogi V; Perioli L; Marmottini F; Rossi C
Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.
Qi S; Weuts I; De Cort S; Stokbroekx S; Leemans R; Reading M; Belton P; Craig DQ
J Pharm Sci; 2010 Jan; 99(1):196-208. PubMed ID: 19492312
[TBL] [Abstract][Full Text] [Related]
15. Formation, physical stability, and quantification of process-induced disorder in cryomilled samples of a model polymorphic drug.
Hu Y; Macfhionnghaile P; Caron V; Tajber L; Healy AM; Erxleben A; McArdle P
J Pharm Sci; 2013 Jan; 102(1):93-103. PubMed ID: 23047833
[TBL] [Abstract][Full Text] [Related]
16. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257
[TBL] [Abstract][Full Text] [Related]
17. Compare and contrast the effects of surfactants (PluronicF-127 and CremophorEL) and sugars (β-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme.
Haj-Ahmad RR; Elkordy AA; Chaw CS; Moore A
Eur J Pharm Sci; 2013 Jul; 49(4):519-34. PubMed ID: 23712374
[TBL] [Abstract][Full Text] [Related]
18. Spray drying of poorly soluble drugs from aqueous arginine solution.
Ojarinta R; Lerminiaux L; Laitinen R
Int J Pharm; 2017 Oct; 532(1):289-298. PubMed ID: 28890173
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures.
Priemel PA; Laitinen R; Barthold S; Grohganz H; Lehto VP; Rades T; Strachan CJ
Int J Pharm; 2013 Nov; 456(2):301-6. PubMed ID: 24012867
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
